397 related articles for article (PubMed ID: 17126499)
1. Assembly of feline calicivirus-like particle and its immunogenicity.
Di Martino B; Marsilio F; Roy P
Vet Microbiol; 2007 Feb; 120(1-2):173-8. PubMed ID: 17126499
[TBL] [Abstract][Full Text] [Related]
2. Potential for broad-spectrum protection against feline calicivirus using an attenuated myxoma virus expressing a chimeric FCV capsid protein.
McCabe VJ; Spibey N
Vaccine; 2005 Nov; 23(46-47):5380-8. PubMed ID: 16176851
[TBL] [Abstract][Full Text] [Related]
3. Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges.
Poulet H; Brunet S; Leroy V; Chappuis G
Vet Microbiol; 2005 Mar; 106(1-2):17-31. PubMed ID: 15737470
[TBL] [Abstract][Full Text] [Related]
4. A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease.
Huang C; Hess J; Gill M; Hustead D
J Feline Med Surg; 2010 Feb; 12(2):129-37. PubMed ID: 19836282
[TBL] [Abstract][Full Text] [Related]
5. Feline calicivirus VP2 is involved in the self-assembly of the capsid protein into virus-like particles.
Di Martino B; Marsilio F
Res Vet Sci; 2010 Oct; 89(2):279-81. PubMed ID: 20362313
[TBL] [Abstract][Full Text] [Related]
6. Serological analysis and identification of feline calicivirus strains isolated in Sicily.
Camero M; Cirone F; Bozzo G; Pennisi MG; Carelli G; Rinaldo D; Buonavoglia D
New Microbiol; 2002 Apr; 25(2):243-6. PubMed ID: 12019733
[TBL] [Abstract][Full Text] [Related]
7. Feline calicivirus strains isolated in Italy.
Rinaldo D; Foti M; Bottari T; Fisichella V; Buonavoglia D
Pol J Vet Sci; 2008; 11(4):359-61. PubMed ID: 19227135
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an avirulent FCV strain with a broad serum cross-neutralization profile and protection against challenge of a highly virulent vs feline calicivirus.
Rong S; Lowery D; Floyd-Hawkins K; King V
Virus Res; 2014 Aug; 188():60-7. PubMed ID: 24685673
[TBL] [Abstract][Full Text] [Related]
9. Genogrouping of vaccine breakdown strains (VBS) of feline calicivirus in Japan.
Ohe K; Sakai S; Takahasi T; Sunaga F; Murakami M; Kiuchi A; Fukuyama M; Furuhata K; Hara M; Ishikawa Y; Taneno A
Vet Res Commun; 2007 May; 31(4):497-507. PubMed ID: 17225086
[TBL] [Abstract][Full Text] [Related]
10. Properties of a calicivirus isolated from cats dying in an agitated state.
Sato Y; Ohe K; Fukuyama M; Furuhata K; Kishikawa S; Sakai S; Kiuchi A; Hara M; Watanabe T; Ishikawa Y; Taneno A
Vet Rec; 2004 Dec 18-25; 155(25):800-5. PubMed ID: 15651548
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the ability of feline calicivirus (FCV) vaccines to neutralise a panel of current UK FCV isolates.
Porter CJ; Radford AD; Gaskell RM; Ryvar R; Coyne KP; Pinchbeck GL; Dawson S
J Feline Med Surg; 2008 Feb; 10(1):32-40. PubMed ID: 17720588
[TBL] [Abstract][Full Text] [Related]
12. Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus.
Gore TC; Lakshmanan N; Williams JR; Jirjis FF; Chester ST; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):213-22. PubMed ID: 17039444
[TBL] [Abstract][Full Text] [Related]
13. Post-exposure treatment of cats with mouse-cat chimeric antibodies against feline herpesvirus type 1 and feline calicivirus.
Umehashi M; Imamura T; Akiyama S; Kimachi K; Tokiyoshi S; Mikami T
J Vet Med Sci; 2002 Nov; 64(11):1017-21. PubMed ID: 12499687
[TBL] [Abstract][Full Text] [Related]
14. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
Scott FW; Geissinger CM
Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
[TBL] [Abstract][Full Text] [Related]
15. Ability of antibodies to two new caliciviral vaccine strains to neutralise feline calicivirus isolates from the UK.
Addie D; Poulet H; Golder MC; McDonald M; Brunet S; Thibault JC; Hosie MJ
Vet Rec; 2008 Sep; 163(12):355-7. PubMed ID: 18806279
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms for persistence of acute and chronic feline calicivirus infections in the face of vaccination.
Pedersen NC; Hawkins KF
Vet Microbiol; 1995 Nov; 47(1-2):141-56. PubMed ID: 8604546
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing feature of commercially available feline calicivirus (FCV) vaccine immune sera against FCV field isolates.
Hohdatsu T; Sato K; Tajima T; Koyama H
J Vet Med Sci; 1999 Mar; 61(3):299-301. PubMed ID: 10331208
[TBL] [Abstract][Full Text] [Related]
18. Temporally separated feline calicivirus isolates do not cluster phylogenetically and are similarly neutralised by high-titre vaccine strain FCV-F9 antisera in vitro.
Smith SL; Afonso MM; Pinchbeck GL; Gaskell RM; Dawson S; Radford AD
J Feline Med Surg; 2020 Jun; 22(6):602-607. PubMed ID: 31411533
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a highly virulent feline calicivirus and attenuation of this virus.
Rong S; Slade D; Floyd-Hawkins K; Wheeler D
Virus Res; 2006 Dec; 122(1-2):95-108. PubMed ID: 16950539
[TBL] [Abstract][Full Text] [Related]
20. Feline calicivirus.
Radford AD; Coyne KP; Dawson S; Porter CJ; Gaskell RM
Vet Res; 2007; 38(2):319-35. PubMed ID: 17296159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
